Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dysimmune peripheral neuropathies].

L Magy1

  • 1Service de Neurologie, CHRU Dupuytren, Limoges. laurent.magy@unilim.fr

Revue Neurologique
|April 6, 2006
PubMed
Summary
This summary is machine-generated.

Functional scales are crucial for evaluating patients with dysimmune peripheral neuropathies and will be vital in future treatment studies. These validated tools help assess the disease

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New double homozygous GDAP1 variations associated with polyneuropathy and prominent inflammatory features in unrelated individuals from Indian Ocean islands.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025
Same author

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

Revue neurologique·2024
Same author

Transient hemi-parkinsonism due to deep brain venous edema induced by severe intracranial hypotension, a case report.

Revue neurologique·2023
Same author

Current clinical management of CIDP with immunoglobulins in France: An expert opinion.

Revue neurologique·2023
Same author

French recommendations for the management of adult & pediatric chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Revue neurologique·2022
Same author

[Muscular weakness and weight loss in à 44 year-old man].

La Revue de medecine interne·2021
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Area of Science:

  • Neurology
  • Clinical Assessment
  • Immunology

Context:

  • Dysimmune peripheral neuropathies present diagnostic challenges due to clinical polymorphism.
  • Functional scales are increasingly recognized for their utility in evaluating disease impact.
  • Recent years have seen significant efforts in validating these scales for routine neurological use.

Purpose:

  • To highlight the growing importance of functional scales in assessing dysimmune peripheral neuropathies.
  • To discuss the challenges in evaluating peripheral neuropathies compared to purely motor disorders.
  • To emphasize the need for validated functional scales in clinical practice and future therapeutic trials.

Summary:

  • Functional scales are essential for evaluating the real-world impact of dysimmune peripheral neuropathies.

Related Experiment Videos

  • These scales are becoming indispensable tools for patient assessment in clinical trials.
  • Ongoing validation efforts aim to integrate these scales into routine neurological practice.

    • Impact:

    • Validated functional scales will improve the consistency and reliability of patient evaluations.
    • Increased use of these scales is expected to enhance the design and outcomes of future therapeutic trials.
    • Standardized assessment tools will facilitate better management and research for peripheral neuropathies.